Price Alert

Bolt Biotherapeutics Inc. (BOLT)

NASDAQ: BOLT · Real-Time Price · USD

5.03

-0.12 (-2.33%)

At close: Aug 18, 2025, 3:59 PM

5.07

0.90%

After-hours: Aug 18, 2025, 04:10 PM EDT

-2.33% (1D)

Bid	4.76
Market Cap	9.63M
Revenue (ttm)	3.64M
Net Income (ttm)	-63.35M
EPS (ttm)	-33.2
PE Ratio (ttm)	-0.15
Forward PE	-0.26
Analyst	Hold

Ask	5.7
Volume	22,629
Avg. Volume (20D)	29,000
Open	5.17
Previous Close	5.15
Day's Range	4.97 - 5.17
52-Week Range	4.97 - 14.36
Beta	0.90

About BOLT

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol BOLT

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BOLT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Bolt Biotherapeutics has released their quartely earnings on Aug 14, 2025:

Revenue of $1.8M exceeds estimates by $896.15K, with 41.49% YoY growth.

EPS of -4.46 exceeds estimates by 1.86, with 60.18% YoY growth.

Next Earnings Release

Bolt Biotherapeutics Inc. is scheduled to release its earnings on Nov 11, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

News

5 days ago · zacks.com

Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $4.46 per share versus the Zacks Consensus Estimate of a loss of $6.4. This compares to a loss of $11.2 per share a year ago.

2 months ago · https://www.defenseworld.net

Squarepoint Ops LLC Buys New Holdings in Bolt Biotherapeutics, Inc. (NASDAQ:BOLT)

Squarepoint Ops LLC purchased a new stake in Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange C...